Phase 2/3 trial data show VDPHL01, an oral non-hormonal extended-release minoxidil, improves hair growth and patient-reported outcomes in male pattern hair loss.

Low dose oral minoxidil yields measurable increases in frontal hair density by 3-6 months, with no further significant gains up to 36 months, a retrospective review finds.

The hair growth industry is entering a new phase, blending pharmaceutical innovation, botanical research, and scalp-focused care. Breakthroughs include an extended-release oral minoxidil pill showing ...

HAIR LOSS: CONFIDENCE -killing, difficult to treat, ubiquitous. In fact, the most common form of shedding —male androgenic ...

This article was reviewed by Sara Harcharik Perkins, MD. Key Takeaways Both topical and oral minoxidil are considered safe for women. They’re effective at treating hair loss. Topical minoxidil is ...

Need a solution for your thinning hair line? We took a deep dive into Hims hair growth program to see how it works and who it works best for.